Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program

/PRNewswire/ -- Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced...

Related Keywords

New York ,United States ,Wilson Sonsini Goodrich Rosati ,Johnson ,Rayees Rahman ,Neil Shah ,Hong Yu Li ,University Of Arkansas ,Bioventures University Of Arkansas ,Prnewswire Harmonic Discovery The Company ,Discovery Inc ,Discovery The Company ,Medical Sciences ,Sonsini Goodrich ,Harmonic Discovery ,Licensing Agreement ,Seed Financing ,Innovation Endeavors ,Fifty Years ,New York City ,Harmonic Discovery Inc ,